Axitinib News and Research

RSS
GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

Axitinib shows promise for patients with advanced kidney cancer

Axitinib shows promise for patients with advanced kidney cancer

Axitinib shows promise in treatment of advanced thyroid cancer

Axitinib shows promise in treatment of advanced thyroid cancer